Integrated Molecular Profiling Improves Subtype Classification and Reveals Inherited Susceptibility in...

Area of Science:

• Oncology
• Genetics
• Pediatric Medicine

Background:

• Medulloblastoma (MB) is a diverse pediatric brain tumor with distinct molecular subtypes.
• Genomics and transcriptomics aid subtype classification and targeted therapies, but real-world clinical utility of integrated profiling is unclear.

Purpose of the Study:

• To evaluate the impact of integrated genomic and transcriptomic profiling in a Chinese cohort of medulloblastoma patients.
• To assess improvements in diagnostic refinement, germline predisposition identification, and actionable alteration detection.

Main Methods:

• Retrospective analysis of 131 pediatric medulloblastoma patients.
• Utilized targeted genomic sequencing and NanoString-based transcriptomic profiling.
• Assessed diagnostic and therapeutic implications of combined molecular data.

Main Results:

• Integrated profiling optimized or revised molecular classification in 67.2% of patients.
• Enrichment of germline variants in Fanconi anemia pathway genes in Group 3 and 4 MB.
• 52.7% of patients had actionable somatic mutations; one WNT-MB case with CDKN2A deletion showed poor outcome.

Conclusions:

• Combined genomic and transcriptomic profiling significantly enhances medulloblastoma subtyping and reveals inherited risk factors.
• Supports integrating combined molecular diagnostics into routine clinical management for MB.
• Highlights potential for guiding individualized treatment strategies in pediatric brain tumors.